Actively Recruiting
A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
Led by Daewon Pharmaceutical Co., Ltd. · Updated on 2026-01-15
150
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
CONDITIONS
Official Title
A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adult aged 19 to 50 (inclusive) years at the time of screening
- Weight between 50 kg and 90 kg
- Body mass index (BMI) between 18 and 27 kg/m2 (inclusive) at screening visit
You will not qualify if you...
- History or presence of significant diseases affecting liver, kidney, nervous system, respiratory system, endocrine system, blood, cancer, heart, urinary system, or mental health
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chungbuk National University Hospital
Cheongju-si, South Korea
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here